drugset / Trial / NCT07386509

WU 345: Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza Vaccines in the Lymphoid Tissues.

NCT07386509

NaSingle-groupOpen-labelBasic science

Summary

Healthy adults (18-49 years of age) with no previous influenza virus vaccination history for at least three years prior to enrollment will be recruited to participate in this study. All subjects will concomitantly receive a single dose of both Fluad® and Afluria® administered intramuscularly in opposite deltoid muscles. Blood samples collected at 9 visits (screening, baseline, days 7, 14, 28, 60, 90, 120 and 180, fine needle aspiration (FNAs) from axillary lymph nodes from both axillae at baseline, days 7, 14, 28, 60, 90, 120 and 180.

Timeline

Start
2020-03-17
Primary completion
2022-11-04
Completion
2022-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Afluria Vaccine Intramuscular
Subject Fluad Vaccine Intramuscular

Indications

No indication recorded.